Capital Flow Monitor · Sponsors · CIK 1701523
Illuminare Biotechnologies Inc
327 St Marks Avenue, Brooklyn, NY, 11238 · 6094971282
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$4.0M
Sold
$3.7M
% sold
91.3%
Investors
42
Min investment
$1K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-06-04 | D ·current | 506(b) | $4.0M | $3.7M | 91.3% | 42 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Robert Graifman — Director / Promoter, Miami Beach, FL
- Oliver Curme — Director, Chestnut Hill, MA
- Shay Grinfeld — Director / Promoter, Hoboken, NJ
- Walter Greenblatt — Executive Officer / Director / Promoter, Brooklyn, NY
-
Eric Edidin — Director, Fort Lauderdale, FL
10 other raises
- BH3 Debt Opportunity Fund III-Offshore L.P. $0 of —
- BH3 Debt Opportunity Fund III L.P. $0 of —
- DOF II-Park Tower Co-Invest LLC $23.7M of $23.7M · 100.0%
- ILIAD BIOTECHNOLOGIES, INC. $115.5M of $115.5M · 100.0%
- BH3 Harel Debt Opportunity Fund, LP $21.0M of $21.0M · 100.0%
- BH3 Heritage FV III Feeder L.P. $15.0M of $50.0M · 30.0%
- Endo Ventures Cecelia SPV, LLC $94K of $94K · 100.0%
- Endo IV Cecelia SPV, LLC $591K of $591K · 100.0%
- Endo G100 Cecelia SPV LLC $109K of $109K · 100.0%
- Cecelia Health Holdings, Inc. $16.1M of $19.1M · 84.3%
- Brian Longstreet — Executive Officer / Director, Westfield, NJ
- Andrew Fradkin — Promoter, Ketchum, ID
- Ezra Angrist — Promoter, Cohoes, NY
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.